Published: 29 April 2021
Author(s): Fabio Angeli, Antonio Spanevello, Gianpaolo Reboldi, Dina Visca, Paolo Verdecchia
Issue: June 2021
Section: Review Article

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread across the world and killed more than 2.9 million individuals globally, with 137 million cases being confirmed by laboratory tests (April 16 2021, https://covid19.who.int/). Thus, there is an ongoing search for therapeutics finalized to block the transition from infection to severe forms of coronavirus disease 2019 (COVID-19).

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.